ATE257014T1 - Lichtbilderzeugungskontrastmitteln - Google Patents

Lichtbilderzeugungskontrastmitteln

Info

Publication number
ATE257014T1
ATE257014T1 AT98919335T AT98919335T ATE257014T1 AT E257014 T1 ATE257014 T1 AT E257014T1 AT 98919335 T AT98919335 T AT 98919335T AT 98919335 T AT98919335 T AT 98919335T AT E257014 T1 ATE257014 T1 AT E257014T1
Authority
AT
Austria
Prior art keywords
light imaging
imaging contrast
contrast agents
molecular weight
range
Prior art date
Application number
AT98919335T
Other languages
English (en)
Inventor
Robert Allen Snow
Paul Mark Henrichs
Daniel Joseph Nycomed Delecki
William A Sanderson
Vinay Chandrakant Desai
Edward Bacon
Kenneth R Hollister
Eric Paul Hohenschuh
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9727124.1A external-priority patent/GB9727124D0/en
Application filed by Amersham Health As filed Critical Amersham Health As
Application granted granted Critical
Publication of ATE257014T1 publication Critical patent/ATE257014T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A61K41/0033—Sonodynamic cancer therapy with sonochemically active agents or sonosensitizers, having their cytotoxic effects enhanced through application of ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A61K49/0034—Indocyanine green, i.e. ICG, cardiogreen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polyethers (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT98919335T 1997-04-29 1998-04-28 Lichtbilderzeugungskontrastmitteln ATE257014T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US84858697A 1997-04-29 1997-04-29
GBGB9727124.1A GB9727124D0 (en) 1997-12-22 1997-12-22 Compounds
US3528598A 1998-03-05 1998-03-05
PCT/GB1998/001244 WO1998048838A1 (en) 1997-04-29 1998-04-28 Compounds

Publications (1)

Publication Number Publication Date
ATE257014T1 true ATE257014T1 (de) 2004-01-15

Family

ID=27269147

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98919335T ATE257014T1 (de) 1997-04-29 1998-04-28 Lichtbilderzeugungskontrastmitteln

Country Status (8)

Country Link
US (1) US6350431B1 (de)
EP (1) EP0979103B1 (de)
JP (1) JP4699575B2 (de)
AT (1) ATE257014T1 (de)
AU (2) AU7221398A (de)
DE (1) DE69820867T2 (de)
ES (1) ES2213899T3 (de)
WO (2) WO1998048845A1 (de)

Families Citing this family (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316153B1 (en) * 1998-04-21 2001-11-13 The University Of Connecticut Free-form fabricaton using multi-photon excitation
GB2337523A (en) * 1998-04-29 1999-11-24 Nycomed Imaging As Light imaging contrast agents
AU4859699A (en) * 1998-07-06 2000-01-24 Pharmacyclics, Inc. Intracellular sensitizers for sonodynamic therapy
US6986740B2 (en) * 1998-11-02 2006-01-17 Xantech Pharmaceuticals, Inc. Ultrasound contrast using halogenated xanthenes
GB9824632D0 (en) * 1998-11-10 1999-01-06 Celltech Therapeutics Ltd Biological compounds
SE9804328D0 (sv) * 1998-12-15 1998-12-15 Christer Busch Contrast agent for facilitating ocular identification and inspection of lymph nodes
US6167297A (en) 1999-05-05 2000-12-26 Benaron; David A. Detecting, localizing, and targeting internal sites in vivo using optical contrast agents
US6217848B1 (en) 1999-05-20 2001-04-17 Mallinckrodt Inc. Cyanine and indocyanine dye bioconjugates for biomedical applications
ATE341345T1 (de) * 1999-06-11 2006-10-15 Cytyc Corp Flüssige gelformulierung zum detektieren von milchkanälen in der brust vor einer chirurgischen ablation des brustgewebes
EP1202671A4 (de) 1999-08-13 2004-11-10 Point Biomedical Corp Mikropartikel verwendbar als ultraschallkontrastmittel für das lymphsystem
EP1088559A3 (de) * 1999-09-29 2002-10-02 INSTITUT FÜR DIAGNOSTIKFORSCHUNG GmbH AN DER FREIEN UNIVERSITÄT BERLIN Galenische Formulierungen
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
US6750037B2 (en) 1999-12-27 2004-06-15 Edwin L. Adair Method of cancer screening primarily utilizing non-invasive cell collection, fluorescence detection techniques, and radio tracing detection techniques
US6395257B1 (en) * 2000-01-18 2002-05-28 Mallinckrodt Inc. Dendrimer precursor dyes for imaging
US7790144B2 (en) 2000-01-18 2010-09-07 Mallinckrodt Inc. Receptor-avid exogenous optical contrast and therapeutic agents
JP2001299676A (ja) 2000-04-25 2001-10-30 Fuji Photo Film Co Ltd センチネルリンパ節検出方法および検出システム
JP2002095663A (ja) * 2000-09-26 2002-04-02 Fuji Photo Film Co Ltd センチネルリンパ節光断層画像取得方法および装置
EP2325263B1 (de) 2000-09-29 2013-01-23 Life Technologies Corporation Modifizierte Carbocyaninfarbstoffe und deren Konjugate
EP1801165B1 (de) 2000-09-29 2012-08-01 Life Technologies Corporation Modifizierte Carbocyanin-Farbstoffe und ihre Konjugate
US6656451B1 (en) * 2000-10-16 2003-12-02 Mallinckrodt, Inc. Indole compounds as novel dyes for organ function monitoring
US6733744B1 (en) * 2000-10-16 2004-05-11 Mallinckrodt Inc. Indole compounds as minimally invasive physiological function monitoring agents
US7556797B2 (en) 2000-10-16 2009-07-07 Mallinckrodt Inc. Minimally invasive physiological function monitoring agents
EP1341557A2 (de) 2000-10-27 2003-09-10 Beth Israel Deaconess Medical Center Nichtisotopischer nachweis von osteoblastischer aktivität in vivo mittels modifizierten bisphosphonaten
DE60141090D1 (de) 2000-10-30 2010-03-04 Gen Hospital Corp Optische systeme zur gewebeanalyse
US9295391B1 (en) 2000-11-10 2016-03-29 The General Hospital Corporation Spectrally encoded miniature endoscopic imaging probe
EP2333521B1 (de) 2001-04-30 2019-12-04 The General Hospital Corporation Verfahren und vorrichtung zur verbesserung der bildklarheit und empfindlichkeit bei der optischen kohärenz-tomographie unter verwendung von dynamischer rückkopplung zur kontrolle der fokussierungseigenschaften und der kohärenzsteuerung
EP1443953A4 (de) * 2001-10-16 2005-11-23 Epix Pharm Inc Nachweis und behandlung von intravaskulären läsionen
US6980299B1 (en) 2001-10-16 2005-12-27 General Hospital Corporation Systems and methods for imaging a sample
US6761878B2 (en) 2001-10-17 2004-07-13 Mallinckrodt, Inc. Pathological tissue detection and treatment employing targeted benzoindole optical agents
US20030105300A1 (en) 2001-10-17 2003-06-05 Mallinckrodt Inc. Tumor targeted photodiagnostic-phototherapeutic agents
BR0207574B1 (pt) * 2001-12-28 2013-12-24 Prysmian Cavi Sistemi Energia Cabo para telecomunicação
US7310150B2 (en) 2002-01-11 2007-12-18 The General Hospital Corporation Apparatus and method for low coherence ranging
US7355716B2 (en) 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
AU2003225763A1 (en) * 2002-03-11 2003-09-29 Visen Medical, Inc. Optical imaging probes
IL164362A0 (en) * 2002-04-02 2005-12-18 Yeda Res & Dev Characterization of moving objects in a stationarybackground
US20040121405A1 (en) * 2002-04-16 2004-06-24 Green Bernard S. Selective covalent-binding compounds having therapeutic diagnostic and analytical applications
US20030225448A1 (en) 2002-05-28 2003-12-04 Scimed Life Systems, Inc. Polar radiopaque marker for stent
US9371559B2 (en) 2002-06-20 2016-06-21 The Regents Of The University Of California Compositions for detection and analysis of polynucleotides using light harvesting multichromophores
US10001475B2 (en) 2002-06-20 2018-06-19 The Regents Of The University Of California Light harvesting multichromophore compositions and methods of using the same
US7144950B2 (en) 2003-09-17 2006-12-05 The Regents Of The University Of California Conformationally flexible cationic conjugated polymers
ATE336266T1 (de) * 2002-06-21 2006-09-15 Adair Edwin Lloyd Anwendung von metalloporphyrinen zur behandlung von arteriosklerose
WO2004002476A2 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
US7053210B2 (en) * 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
CA2497152C (en) * 2002-08-26 2016-06-07 The Regents Of The University Of California Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
US20040115754A1 (en) * 2002-12-11 2004-06-17 Umax Data Systems Inc. Method for establishing a long-term profile of blood sugar level aiding self-control of the same
TWI309571B (en) * 2002-12-31 2009-05-11 Ind Tech Res Inst Delivery carrier for targeting cells haring over-expressed estrogen
TW200411178A (en) * 2002-12-31 2004-07-01 Veutron Corp Method for determining the resolution of blood glucose by using rising time curve
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
US7643153B2 (en) 2003-01-24 2010-01-05 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
CN1771335A (zh) * 2003-02-13 2006-05-10 加州大学评议会 使用集光多生色团检测和分析多核苷酸－结合蛋白相互作用的方法和组合物
JP2004269439A (ja) * 2003-03-10 2004-09-30 Motohiro Takeda センチネルリンパ節検出剤及び検出方法
CA2519937C (en) 2003-03-31 2012-11-20 Guillermo J. Tearney Speckle reduction in optical coherence tomography by path length encoded angular compounding
TW592667B (en) * 2003-04-04 2004-06-21 Veutron Corp Method for determining the resolution of blood glucose
US7850946B2 (en) 2003-05-31 2010-12-14 Washington University In St. Louis Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
KR101204370B1 (ko) 2003-06-06 2012-11-23 더 제너럴 하스피탈 코포레이션 파장 동조 소스용 방법 및 장치
US7332477B2 (en) * 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
WO2005032597A1 (en) * 2003-09-29 2005-04-14 Nitto Denko Corporation Biodegradable polyacetals for in vivo polynucleotide delivery
WO2005047813A1 (en) 2003-10-27 2005-05-26 The General Hospital Corporation Method and apparatus for performing optical imaging using frequency-domain interferometry
EP1687587B1 (de) 2003-11-28 2020-01-08 The General Hospital Corporation Verfahren und vorrichtung für dreidimensionale spektralcodierte bildgebung
US20050171424A1 (en) * 2004-01-13 2005-08-04 The Gov. Of The Usa As Rep. By The Secretary Of The Dept. Of Health And Human Services Methods for imaging the lymphatic system using dendrimer-based contrast agents
US7302846B2 (en) * 2004-03-12 2007-12-04 Hadala Anthony J Temperature-sensing device for determining the level of a fluid
EP2438847A3 (de) * 2004-06-18 2012-11-07 David R. Elmaleh Kontrastmittel und dessen Verwendung in einer Intravaskuläre Bildgebungsvorrichtung
CA2572226A1 (en) * 2004-06-28 2006-02-02 Bruce R. Line Radiolabeled nanohybrids targeting solid tumor neovasculature and method of using same
JP4995720B2 (ja) 2004-07-02 2012-08-08 ザ ジェネラル ホスピタル コーポレイション ダブルクラッドファイバを有する内視鏡撮像プローブ
JP5053845B2 (ja) 2004-08-06 2012-10-24 ザ ジェネラル ホスピタル コーポレイション 光学コヒーレンス断層撮影法を使用して試料中の少なくとも１つの位置を決定するための方法、システムおよびソフトウェア装置
JP5324095B2 (ja) 2004-08-24 2013-10-23 ザ ジェネラル ホスピタル コーポレイション 血管セグメントを画像化する方法および装置
ATE538714T1 (de) 2004-08-24 2012-01-15 Gen Hospital Corp Verfahren, system und software-anordnung zur bestimmung des elastizitätsmoduls
KR101269455B1 (ko) 2004-09-10 2013-05-30 더 제너럴 하스피탈 코포레이션 광 간섭 영상화를 위한 시스템 및 방법
EP1804638B1 (de) 2004-09-29 2012-12-19 The General Hospital Corporation System und verfahren zur abbildung optischer kohärenz
EP1655040A1 (de) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Kontrastmittel Zusammensetzungen für die Bildgebung des Lymphsystems
JP5623692B2 (ja) 2004-11-02 2014-11-12 ザ ジェネラル ホスピタル コーポレイション 試料の画像形成のための光ファイバ回転装置、光学システム及び方法
JP4597744B2 (ja) 2004-11-08 2010-12-15 株式会社トプコン 光画像計測装置及び光画像計測方法
EP1816949A1 (de) 2004-11-29 2007-08-15 The General Hospital Corporation Anordnungen, vorrichtungen, endoskope, katheter und verfahren für die optische bilddarstellung durch gleichzeitige beleuchtung und nachweis von mehreren punkten auf einer probe
WO2006074482A2 (en) * 2005-01-10 2006-07-13 The Regents Of The University Of California Methods and kits for strand-specific polynucleotide detection with cationic multichromophores
WO2006074471A2 (en) 2005-01-10 2006-07-13 The Regents Of The University Of California Cationic conjugated polymers suitable for strand-specific polynucleotide detection in homogeneous and solid state assays
US7666594B2 (en) * 2005-01-31 2010-02-23 The Regents Of The University Of California Methods for assaying a sample for an aggregant
US20060204443A1 (en) * 2005-03-11 2006-09-14 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Methods for tumor treatment using dendrimer conjugates
US7674452B2 (en) * 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
US7432027B2 (en) * 2005-03-30 2008-10-07 Xerox Corporation Dual-layer protected transient document
US8351665B2 (en) 2005-04-28 2013-01-08 The General Hospital Corporation Systems, processes and software arrangements for evaluating information associated with an anatomical structure by an optical coherence ranging technique
WO2006121984A2 (en) * 2005-05-06 2006-11-16 Yeda Research And Development Co., Ltd. Erythrocyte movement imaging and analysis
US20070121196A1 (en) 2005-09-29 2007-05-31 The General Hospital Corporation Method and apparatus for method for viewing and analyzing of one or more biological samples with progressively increasing resolutions
WO2007084903A2 (en) 2006-01-19 2007-07-26 The General Hospital Corporation Apparatus for obtaining information for a structure using spectrally-encoded endoscopy techniques and method for producing one or more optical arrangements
EP2289397A3 (de) 2006-01-19 2011-04-06 The General Hospital Corporation Verfahren und Systeme zur optischen Bildgebung von epithelialen Luminalorganen durch Strahlenabtastung dieser
JP2009537024A (ja) 2006-02-01 2009-10-22 ザ ジェネラル ホスピタル コーポレイション 少なくとも一つのファイバの少なくとも二つの部位の少なくとも一つを制御する装置
WO2007149602A2 (en) 2006-02-01 2007-12-27 The General Hospital Corporation Methods and systems for providing electromagnetic radiation to at least one portion of a sample using conformal laser therapy procedures
EP1986545A2 (de) 2006-02-01 2008-11-05 The General Hospital Corporation Vorrichtung zur anwendung mehrerer elektromagnetischer strahlungen auf einer probe
JP5519152B2 (ja) 2006-02-08 2014-06-11 ザ ジェネラル ホスピタル コーポレイション 光学顕微鏡法を用いて解剖学的サンプルに関わる情報を取得するための装置
WO2007101026A2 (en) 2006-02-24 2007-09-07 The General Hospital Corporation Methods and systems for performing angle-resolved fourier-domain optical coherence tomography
AP2402A (en) * 2006-03-20 2012-04-30 Pfizer Ltd Amine derivatives.
US20070248890A1 (en) * 2006-04-20 2007-10-25 Inphase Technologies, Inc. Index Contrasting-Photoactive Polymerizable Materials, and Articles and Methods Using Same
EP2015669A2 (de) 2006-05-10 2009-01-21 The General Hospital Corporation Verfahren, anordnungen und systeme für frequenzbereichsabbildung einer probe
US20070297988A1 (en) * 2006-06-21 2007-12-27 Bin Wu Optical probes for in vivo imaging
US7993927B2 (en) 2006-07-03 2011-08-09 Beth Israel Deaconess Medical Center, Inc. Histology methods
JP5420414B2 (ja) 2006-10-06 2014-02-19 シリゲン グループ リミテッド 指向性バイオマーカシグナル増幅用の蛍光方法および材料
US8838213B2 (en) 2006-10-19 2014-09-16 The General Hospital Corporation Apparatus and method for obtaining and providing imaging information associated with at least one portion of a sample, and effecting such portion(s)
WO2008102065A1 (fr) * 2007-02-14 2008-08-28 Commissariat A L'energie Atomique Emulsions fluorescentes pour l'imagerie optique
US9176319B2 (en) 2007-03-23 2015-11-03 The General Hospital Corporation Methods, arrangements and apparatus for utilizing a wavelength-swept laser using angular scanning and dispersion procedures
US10534129B2 (en) 2007-03-30 2020-01-14 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque
WO2009018456A2 (en) 2007-07-31 2009-02-05 The General Hospital Corporation Systems and methods for providing beam scan patterns for high speed doppler optical frequency domain imaging
US20090062724A1 (en) * 2007-08-31 2009-03-05 Rixen Chen System and apparatus for sonodynamic therapy
US8403862B2 (en) * 2007-12-20 2013-03-26 Yeda Research And Development Co. Ltd. Time-based imaging
US11123047B2 (en) 2008-01-28 2021-09-21 The General Hospital Corporation Hybrid systems and methods for multi-modal acquisition of intravascular imaging data and counteracting the effects of signal absorption in blood
US9332942B2 (en) 2008-01-28 2016-05-10 The General Hospital Corporation Systems, processes and computer-accessible medium for providing hybrid flourescence and optical coherence tomography imaging
WO2009100011A2 (en) * 2008-02-01 2009-08-13 University Of Florida Research Foundation, Inc. Targeted cellular selectivity of surface active molecules
US20090214436A1 (en) 2008-02-18 2009-08-27 Washington University Dichromic fluorescent compounds
JP5795531B2 (ja) 2008-06-20 2015-10-14 ザ ジェネラル ホスピタル コーポレイション フューズドファイバオプティックカプラ構造、及びその使用方法
EP2309923B1 (de) 2008-07-14 2020-11-25 The General Hospital Corporation Vorrichtung und verfahren für eine farbendoskopie
FR2935001B1 (fr) * 2008-08-14 2011-12-30 Commissariat Energie Atomique Emulsion fluorescente
FR2934954B1 (fr) 2008-08-14 2011-07-22 Commissariat Energie Atomique Emulsion fluorescente de vert d'indocyanine
FR2934955B1 (fr) 2008-08-14 2011-07-08 Commissariat Energie Atomique Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions
FR2934953B1 (fr) 2008-08-14 2011-01-21 Commissariat Energie Atomique Nanoemulsions de nanocristaux
US20100098637A1 (en) * 2008-09-23 2010-04-22 The Regents Of The University Of Michigan Dye-loaded nanoparticle
JP5731394B2 (ja) 2008-12-10 2015-06-10 ザ ジェネラル ホスピタル コーポレイション 光サブサンプリングを通じて、光コヒーレンストモグラヒィーのイメージング深度範囲を伸ばすためのシステム、装置及び方法
WO2010091190A2 (en) 2009-02-04 2010-08-12 The General Hospital Corporation Apparatus and method for utilization of a high-speed optical wavelength tuning source
WO2010105197A2 (en) 2009-03-12 2010-09-16 The General Hospital Corporation Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s)
KR20110138246A (ko) 2009-03-19 2011-12-26 제너럴 일렉트릭 캄파니 광학 영상화제
US9198985B2 (en) 2009-05-22 2015-12-01 Vanderbuilt University Bimodal star polymer architectures as fluorescent and MRI imaging reagents
SG177355A1 (en) 2009-06-26 2012-02-28 Sirigen Inc Signal amplified biological detection with conjugated polymers
CN102469943A (zh) 2009-07-14 2012-05-23 通用医疗公司 用于测量脉管内流动和压力的设备、系统和方法
WO2011035140A1 (en) 2009-09-18 2011-03-24 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of contrast moieties to the lungs
TWI391144B (zh) * 2009-10-26 2013-04-01 Iner Aec Executive Yuan 一種定量肝殘餘功能的檢驗方法與其新穎肝受體造影檢驗藥劑
ES2977359T3 (es) 2010-01-19 2024-08-22 Sirigen Ii Ltd Nuevos reactivos para la amplificación dirigida de la señal de un biomarcador
SMT202000624T1 (it) 2010-03-05 2021-01-05 Massachusetts Gen Hospital Apparecchio per fornire radiazione elettromagnetica a un campione
EP2553527A4 (de) 2010-03-26 2015-11-11 Hitachi Chemical Co Ltd Wasserlösliche nahinfraroterfassungspolymere mit geringen bandlücken
US9069130B2 (en) 2010-05-03 2015-06-30 The General Hospital Corporation Apparatus, method and system for generating optical radiation from biological gain media
US9557154B2 (en) 2010-05-25 2017-01-31 The General Hospital Corporation Systems, devices, methods, apparatus and computer-accessible media for providing optical imaging of structures and compositions
EP2575598A2 (de) 2010-05-25 2013-04-10 The General Hospital Corporation Vorrichtungen, systeme, verfahren und computerlesbares medium zur spektralanalyse von bildern aus einer optischen kohärenz-tomographie
US9302018B2 (en) 2010-05-31 2016-04-05 Eisai R&D Management Co., Ltd. Fluorescent probe for imaging lymph nodes
US10285568B2 (en) 2010-06-03 2019-05-14 The General Hospital Corporation Apparatus and method for devices for imaging structures in or at one or more luminal organs
WO2012033539A1 (en) 2010-09-10 2012-03-15 Hitachi Chemical Co., Ltd. Individually addressable band electrode arrays and methods to prepare the same
GB201015806D0 (en) 2010-09-21 2010-10-27 Ge Healthcare As Vascular imaging agents
WO2012058381A2 (en) 2010-10-27 2012-05-03 The General Hospital Corporation Apparatus, systems and methods for measuring blood pressure within at least one vessel
US20120121518A1 (en) * 2010-11-16 2012-05-17 Zhihua Lu Multifunctional imaging and therapeutic nanoparticles
US9052289B2 (en) 2010-12-13 2015-06-09 Schlumberger Technology Corporation Hydrogen sulfide (H2S) detection using functionalized nanoparticles
US10053447B2 (en) 2010-12-21 2018-08-21 Pierce Biotechnology, Inc Fluorescent compounds
US8889884B1 (en) 2011-07-14 2014-11-18 Pierce Biotechnology, Inc. Phosphine derivatives of fluorescent compounds
WO2013013049A1 (en) 2011-07-19 2013-01-24 The General Hospital Corporation Systems, methods, apparatus and computer-accessible-medium for providing polarization-mode dispersion compensation in optical coherence tomography
US9249307B2 (en) 2011-08-16 2016-02-02 Pierce Biotechnology, Inc. Benzocyanine compounds
WO2013029047A1 (en) 2011-08-25 2013-02-28 The General Hospital Corporation Methods, systems, arrangements and computer-accessible medium for providing micro-optical coherence tomography procedures
US8878918B2 (en) 2011-09-16 2014-11-04 The Invention Science Fund I, Llc Creating a subsurface feature atlas of at least two subsurface features
GB201116733D0 (en) 2011-09-28 2011-11-09 Ge Healthcare As Peptide margin imaging agents
EP2769491A4 (de) 2011-10-18 2015-07-22 Gen Hospital Corp Vorrichtung und verfahren zur herstellung und/oder bereitstellung rezirkulierender optischer verzögerung(en)
EP3553075B1 (de) 2012-01-23 2025-01-08 Washington University Brillenbildgebungssysteme und -verfahren
US9751868B2 (en) 2012-02-28 2017-09-05 Pierce Biotechnology, Inc. Benzocyanine compounds
CN104395306B (zh) 2012-03-02 2019-04-23 皮尔斯生物科技有限公司 作为生物分子的标记染料的吲哚衍生物
WO2013148306A1 (en) 2012-03-30 2013-10-03 The General Hospital Corporation Imaging system, method and distal attachment for multidirectional field of view endoscopy
US11490797B2 (en) 2012-05-21 2022-11-08 The General Hospital Corporation Apparatus, device and method for capsule microscopy
CN104470546B (zh) 2012-07-20 2018-02-27 佳能株式会社 化合物和含有所述化合物的光声成像造影剂
US9415550B2 (en) 2012-08-22 2016-08-16 The General Hospital Corporation System, method, and computer-accessible medium for fabrication miniature endoscope using soft lithography
US9676787B2 (en) 2012-08-28 2017-06-13 Pierce Biotechnology, Inc. Benzopyrylium compounds
WO2014120791A1 (en) 2013-01-29 2014-08-07 The General Hospital Corporation Apparatus, systems and methods for providing information regarding the aortic valve
US11179028B2 (en) 2013-02-01 2021-11-23 The General Hospital Corporation Objective lens arrangement for confocal endomicroscopy
WO2014144709A2 (en) 2013-03-15 2014-09-18 The General Hospital Corporation Methods and systems for characterizing an object
US9784681B2 (en) 2013-05-13 2017-10-10 The General Hospital Corporation System and method for efficient detection of the phase and amplitude of a periodic modulation associated with self-interfering fluorescence
EP3003396B1 (de) 2013-05-24 2020-04-08 University Health Network Multimodale optische ct-mittel
US10117576B2 (en) 2013-07-19 2018-11-06 The General Hospital Corporation System, method and computer accessible medium for determining eye motion by imaging retina and providing feedback for acquisition of signals from the retina
WO2015009932A1 (en) 2013-07-19 2015-01-22 The General Hospital Corporation Imaging apparatus and method which utilizes multidirectional field of view endoscopy
WO2015013651A2 (en) 2013-07-26 2015-01-29 The General Hospital Corporation System, apparatus and method utilizing optical dispersion for fourier-domain optical coherence tomography
WO2015105870A1 (en) 2014-01-08 2015-07-16 The General Hospital Corporation Method and apparatus for microscopic imaging
US10736494B2 (en) 2014-01-31 2020-08-11 The General Hospital Corporation System and method for facilitating manual and/or automatic volumetric imaging with real-time tension or force feedback using a tethered imaging device
WO2015153982A1 (en) 2014-04-04 2015-10-08 The General Hospital Corporation Apparatus and method for controlling propagation and/or transmission of electromagnetic radiation in flexible waveguide(s)
WO2016015052A1 (en) 2014-07-25 2016-01-28 The General Hospital Corporation Apparatus, devices and methods for in vivo imaging and diagnosis
WO2016179350A1 (en) 2015-05-06 2016-11-10 Washington University Compounds having rd targeting motifs and methods of use thereof
WO2017218764A1 (en) * 2016-06-16 2017-12-21 Beloteca, Inc. Method for preparation of isosulfan blue
JP6887020B2 (ja) 2018-03-16 2021-06-16 株式会社東芝 生分解性化合物、脂質粒子、脂質粒子を含む組成物、およびキット
EP3946456A4 (de) * 2019-03-29 2023-05-03 The Brigham and Women's Hospital, Inc. Zielgerichtete synergistische krebsimmuntherapie
CN109966267A (zh) * 2019-05-06 2019-07-05 上海师范大学 纳米声敏剂在制备基于光声引导的声动力学治疗肿瘤药物中的用途
WO2021119423A1 (en) 2019-12-13 2021-06-17 Washington University Near infrared fluorescent dyes, formulations and related methods
CN117203278A (zh) * 2021-03-15 2023-12-08 多伦多大学理事会 具有控制标记水平的金属标记的聚合物微珠
EP4337221A4 (de) 2021-05-10 2025-06-18 University of Mississippi Farbstoffe auf silikonbasis und verfahren zur herstellung und verwendung davon

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
JP2640293B2 (ja) * 1990-05-30 1997-08-13 ドイチエス クレープスフオルシユングスツエントルム ステイフツング デス アフエントリヒエン レヒトス ポリエーテル置換抗腫瘍剤
US5622685A (en) 1990-05-30 1997-04-22 Deutches Krebsforchunszentrum Stiftung Des Offentlichen Rechts Polyether-substituted porphyrin anti-tumor agents
DE4017439C2 (de) * 1990-05-30 1994-06-23 Deutsches Krebsforsch Polyethersubstituierte Tumormittel
WO1992000748A1 (en) * 1990-07-06 1992-01-23 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5155149A (en) * 1991-10-10 1992-10-13 Boc Health Care, Inc. Silicone polyurethane copolymers containing oxygen sensitive phosphorescent dye compounds
US5508289A (en) * 1994-03-14 1996-04-16 The United States America As Represented By The Department Of Health And Human Services Bis-acridone chemotherapeutic derivatives
DE19539409C2 (de) * 1995-10-11 1999-02-18 Diagnostikforschung Inst Kontrastmittel für die Nahinfrarot-Diagnostik
US5709845A (en) * 1996-05-13 1998-01-20 Rajagopalan; Raghavan Tricyclic functional dyes for contrast enhancement in optical imaging

Also Published As

Publication number Publication date
JP2002504894A (ja) 2002-02-12
AU7221298A (en) 1998-11-24
US6350431B1 (en) 2002-02-26
ES2213899T3 (es) 2004-09-01
DE69820867T2 (de) 2004-11-18
WO1998048838A8 (en) 2000-04-27
AU7221398A (en) 1998-11-24
WO1998048845A1 (en) 1998-11-05
JP4699575B2 (ja) 2011-06-15
WO1998048838A1 (en) 1998-11-05
EP0979103A1 (de) 2000-02-16
EP0979103B1 (de) 2004-01-02
DE69820867D1 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
DE69820867D1 (de) Lichtbilderzeugungskontrastmitteln
DE69503003D1 (de) Perfluoropolyether Schmiermittelzusammensetzungen
RU97118224A (ru) Соединения и композиции для доставки активных агентов
DE69004083D1 (de) Polyalkylenglycolschmiermittelzusammensetzungen.
ITTO950777A0 (it) Misura di impedenza transvalvolare adatta all'uso in dispositivi im- piantabili.
ITRM920476A0 (it) Formulazioni galeniche contenenti ciclosporina.
DE69711686D1 (de) Molybdänkomplexe enthaltende schmiermittelzusammensetzungen
TR199802216T2 (xx) Temizleme bile�imleri.
EP0599532A3 (de) Härtbare Einkomponenten-Organosiloxanzusammensetzungen.
DE69405785D1 (de) Fluorosiloxantrennmittelzusammensetzungen
DE60020911D1 (de) Perfluorpolyätherschmiermittel enthaltend Sulfonyfluorgruppe
PL343607A1 (en) Poly(alkylene arylates) having optical properties
DE69106925D1 (de) Härtbare fluoreszierende Siloxanzusammensetzungen.
IT1282402B1 (it) Composizioni acquose di tensioattivi ad elevata viscosita'
ITBO940223A0 (it) Iniettore ad alta capacita' di atomazione.
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
DK1073447T3 (da) N1-modificerede glycopeptider
ITTO950265A0 (it) "tavola allungabile"
FI943069A7 (fi) Kloorittomia, mahdollisesti vetypitoisia fluorihiilivetyjä sisältävät koostumukset
FR2695297B1 (fr) Composition d'agent désinfectant.
EP0866709A4 (de) 1,2,4-benzotriazinoxid-formulierungen
IT1270961B (it) Composizioni poliestere ad elevata viscosita'
IT1272346B (it) "accessorio di raccordo".
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
ITTO950801A0 (it) Dispositivo di connessione elettrica, ad esempio per uso in ambito biomedicale

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties